复发的第二个三个月欧类妊娠损失与母亲和父亲的HLA兼容性相关:基于免疫媒介失败病例报告的审查
Sonia Gayete-Lafuente1,2, Lara Guijarro-Baude1,3, Elizabeth Choong1
1Center For Human Reproduction (CHR), New York, New York, USA.
American journal of reproductive immunology (New York, N.Y. : 1989)
|February 15, 2026
概括
过度的人类白细胞抗原 (HLA) 在父母之间共享可能会导致重复的妊娠损失通过损害母胎免疫耐受性. 这凸显了在无法解释的生殖功能衰竭中需要个性化免疫学评估的需要.
科学领域:
- 生殖免疫学 生殖免疫学
- 免疫遗传学 免疫遗传学
背景情况:
- 复发性流产 (RPL) 通常是无法解释的,有越来越多的证据表明非免疫因素.
- 母亲和父亲之间的人类白细胞抗原 (HLA) 兼容性是破坏母胎免疫耐受性的潜在机制.
研究的目的:
- 为了检查HLA共享在复发的euploid怀孕损失中的作用.
- 用一个代表性临床病例将免疫机制置于背景中.
主要方法:
- 关于RPL中非免疫机制的叙事文献综述,包括HLA和KIR-HLA相互作用.
- 一个临床病例的分析,尽管接受了免疫疗法,但在第二季度出现了复发性欧普洛伊德损失.
主要成果:
- 患者经历了多次euploid损失,尽管全面的免疫疗法.
- 在多个位点观察到广泛的HLA等位基共享,这表明母胎免疫遗传多样性减少.
- 这种HLA共享模式支持了受损的热囊细胞免疫信号传递的拟议机制.
结论:
- 过度的母亲和父亲的HLA兼容性可能会通过破坏免疫耐受性,导致重复的欧普洛伊德妊娠损失.
- 对非免疫媒介的生殖衰竭需要个性化免疫评估和向治疗.
关键词:
哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈没有任何免疫.欧普洛伊德流产流产免疫疗法 免疫疗法经常发生的怀孕流产.更多相关视频
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
3.8K
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
1.9K
相关概念视频
Transcytosis of IgG
3.4K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.4K
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Rh Blood Group
4.3K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.3K
Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Cytomegalovirus Disease
102
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
